Reply to: Moyamoya disease and systemic sclerosis (MoSys syndrome): A combination of two rare entities - comment to the authors

^*Corresponding author for this work

Original language	English
Journal	Clinical and Experimental Rheumatology
Volume	35
Pages (from-to)	217-217
Number of pages	1
ISSN	0392-856X
Publication status	Published - 2017

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

@article{5b53b7eea7bd48a5b8a58fdbe4f39c35,

title = "Reply to: Moyamoya disease and systemic sclerosis (MoSys syndrome): A combination of two rare entities - comment to the authors",

author = "F. Wegner and Ulf M{\"u}ller-Ladner and Meier, \{F. M.P.\}",

year = "2017",

language = "English",

volume = "35",

pages = "217--217",

journal = "Clinical and Experimental Rheumatology",

issn = "0392-856X",

publisher = "Clinical and Experimental Rheumatology S.A.S.",

}

TY - JOUR

T1 - Reply to: Moyamoya disease and systemic sclerosis (MoSys syndrome): A combination of two rare entities - comment to the authors

AU - Wegner, F.

AU - Müller-Ladner, Ulf

AU - Meier, F. M.P.

PY - 2017

Y1 - 2017

UR - https://www.scopus.com/pages/publications/85031670637

M3 - Letters

C2 - 28516875

AN - SCOPUS:85031670637

SN - 0392-856X

VL - 35

SP - 217

EP - 217

JO - Clinical and Experimental Rheumatology

JF - Clinical and Experimental Rheumatology

ER -